Repository logo


In vitro and in vivo studies of boron conjugated melanoma affined biochemicals

Simple item page
dc.contributor.authorAllen, BJen_AU
dc.contributor.authorBrown, JKen_AU
dc.contributor.authorMountford, MHen_AU
dc.contributor.authorTamat, SRen_AU
dc.contributor.authorParwardhan, Aen_AU
dc.contributor.authorMoore, DEen_AU
dc.contributor.authorIchihashi, Men_AU
dc.contributor.authorMishima, Yen_AU
dc.contributor.authorKahl, SBen_AU
dc.date.accessioned2026-01-16T03:06:21Zen_AU
dc.date.available2026-01-16T03:06:21Zen_AU
dc.date.issued1989en_AU
dc.date.statistics2025-11-24en_AU
dc.descriptionPhysical copies held by ANSTO Library at DDC: 616.9440642/30en_AU
dc.description.abstractThe incidence of malignant melanoma (MM) is increasing in caucasians, and in Australia the rate has doubled since the seventies. Queensland has the highest incidence in the world at 33 cases per 100000 people. This increased frequency and poor prognosis for advanced cases has prompted an increased interest in new therapeutic methods. One such method is neutron capture therapy (NCT) which relies on the incorporation of boron compounds in cancer cells. Most of the NCT experiments reported to date have used the B16 murine [3, 4] and HP hamster [2] melanoma cell lines. In order to provide evidence for the wider application of NCT, we have targeted several human MM cell lines with boron conjugated phenylalianine (BPA) [4] and tetraphenylporphyrin (BTPP) [5]. © Urban & Vogel GmbHen_AU
dc.identifier.citationAllen, B. J., Brown, J. K., Mountford, M. H., Tamat, S. R., Patwardhan, A., Moore, D. E., Ichihashi, M., Mishima, Y., & Kahl, S. B. (1989). In vitro and in vivo studies of boron conjugated melanoma affined biochemicals. Paper presented to the Third International Symposium on Neutron Capture Therapy, Bremen 31 May-3 June 1988, in Strahlenther und Onkologie, 165(2-3), 163-165.en_AU
dc.identifier.conferenceenddate1988-06-03en_AU
dc.identifier.conferencenameThird International Symposium on Neutron Capture Therapyen_AU
dc.identifier.conferenceplaceBremenen_AU
dc.identifier.conferencestartdate1988-05-31en_AU
dc.identifier.issn0179-7158en_AU
dc.identifier.issue2-3en_AU
dc.identifier.journaltitleStrahlenther und Onkologieen_AU
dc.identifier.pagination163-165en_AU
dc.identifier.urihttps://apo.ansto.gov.au/handle/10238/16899en_AU
dc.identifier.volume156en_AU
dc.language.isoenen_AU
dc.publisherUrban & Vogel GmbHen_AU
dc.subjectBoron compoundsen_AU
dc.subjectIn vitroen_AU
dc.subjectIn vivoen_AU
dc.subjectIntraperitoneal injectionen_AU
dc.subjectMelanomasen_AU
dc.subjectMiceen_AU
dc.subjectNeutron capture therapyen_AU
dc.subjectOrgansen_AU
dc.subjectPhenylalanineen_AU
dc.subjectPorphyrinsen_AU
dc.subjectTissue Distributionen_AU
dc.subjectUptakeen_AU
dc.titleIn vitro and in vivo studies of boron conjugated melanoma affined biochemicalsen_AU
dc.typeConference Paperen_AU

Files

License bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
license.txt
Size:
1.63 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

Conference Publications